Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Kordower, Jeffrey

One or more keywords matched the following items that are connected to Kordower, Jeffrey

Item Type	Name
Concept	Genetic Therapy
Academic Article	Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
Academic Article	Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
Academic Article	A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
Academic Article	A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
Academic Article	Neurotrophic factor therapy for Parkinson's disease.
Academic Article	Future of cell and gene therapies for Parkinson's disease.
Academic Article	Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Academic Article	AAV2-Neurturin for Parkinson's Disease: What Lessons Have We Learned?
Academic Article	Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
Academic Article	Introduction: gene therapy has gone from a pipe dream to clinical reality.
Academic Article	GDNF family ligands: a potential future for Parkinson's disease therapy.
Academic Article	Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.
Academic Article	In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
Academic Article	Trophic factor gene therapy for Parkinson's disease.
Academic Article	Gene therapy for Huntington's disease.
Academic Article	Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease.
Academic Article	AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease.
Academic Article	Gene therapy for Parkinson's disease: still a hot topic?
Academic Article	Gene therapy approaches for the treatment of Parkinson's disease.
Academic Article	Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration.
Academic Article	Gene therapy for Parkinson's disease.
Academic Article	Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.
Academic Article	Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?
Academic Article	Cell transplantation and gene therapy in Parkinson's disease.
Academic Article	Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
Academic Article	Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys.
Academic Article	Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
Academic Article	Trophic factors therapy in Parkinson's disease.
Academic Article	Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.
Academic Article	Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
Academic Article	Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Academic Article	Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with a-synucleinopathies.
Academic Article	Therapeutic approaches to target alpha-synuclein pathology.
Academic Article	Disease Modification Through Trophic Factor Delivery.
Academic Article	Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
Academic Article	Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease.
Academic Article	GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.
Academic Article	Anti-a-synuclein ASO delivered to monoamine neurons prevents a-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys.
Academic Article	Post-Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10?Years CERE120 Delivery.

Search Criteria

Genetic Therapy